Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Axis NIFTY Healthcare ETF Reg (G) |
[Equity: Sectoral] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
-0.06 |
Equity |
99.91 |
Trep |
0.15 |
|
|
Concentration Analysis |
Top 5 Holdings |
52.44% |
Top 10 Holdings |
77.56% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
76.72 |
Healthcare |
23.19 |
Cash |
0.09 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
5.26 |
PE Ratio |
37.69 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
17.97 |
Cipla Limited |
9.33 |
Max Healthcare Institute Limited |
8.97 |
DIVI LABORATORIES LTD |
8.14 |
Apollo Hospitals Enterprise Limited |
8.03 |
Dr Reddys Laboratories Limited |
8.01 |
Fortis Health Care Ltd |
4.95 |
Lupin Limited |
4.78 |
Torrent Pharmaceuticals Limited |
3.88 |
Laurus Labs Limited |
3.50 |
Glenmark Pharmaceuticals Limited |
3.02 |
Aurobindo Pharma Limited |
3.00 |
Alkem Laboratories Limited |
2.98 |
MANKIND PHARMA LIMITED |
2.91 |
Zydus Lifesciences Limited |
2.56 |
Biocon Limited |
2.19 |
IPCA Laboratories Limited |
2.01 |
Abbott India Limited |
1.70 |
Syngene International Limited |
1.24 |
Granules India Limited |
0.74 |
Tri Party Repo |
0.15 |
Net Receivables / (Payables) |
-0.06 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|